Avizen Biopharma Private Limited

Avizen Biopharma Private Limited - pharma in Guwahati, Assam, India. FY 2026 financials & compliance.
CIN U24304AS2016PTC017532 Incorporated 09 August 2016 ROC Guwahati HQ Guwahati, Assam, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹20.61 Cr
▲ 272% YoY
Net profit · FY 2025
₹32.92 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹1.1 Cr
EBITDA margin 5.3%
Authorised capital
₹5.5 Cr
Registered with MCA
Paid-up capital
₹5.42 Cr
Issued & subscribed
Open charges
₹6.1 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
13
Provident fund records

About Avizen Biopharma Private Limited

Data last updated:

Avizen Biopharma Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 August 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24304AS2016PTC017532. Its GSTIN is 18AAOCA6748E1ZC (Assam). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹5.42 Cr. It is led by directors including Rajendra Kumar Verma and Mahendra Kumar Verma.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sagar Bizz Plex 1st Floor S.R. Bora Lane G.S. Road Ulubari, Guwahati, Assam, India – 781007.

As per the financials filed for FY 2025, the company reported a revenue of ₹20.61 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹32.92 Lakh (net margin 1.6%) and EBITDA of ₹1.1 Cr (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 65% over three years and 68% over five years.

The company has about 13 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹6.1 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 3 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Avizen Biopharma Private Limited
CIN U24304AS2016PTC017532
Registration Number 017532
Incorporation Date 09 August 2016
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Sagar Bizz Plex 1st Floor S.R. Bora Lane G.S. Road Ulubari, Guwahati, Assam, India – 781007
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Avizen Biopharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Avizen Biopharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Avizen Biopharma Private Limited in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Business Activity of Avizen Biopharma Private Limited

The main business activity of Avizen Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Avizen Biopharma Private Limited FY 2024 filings available

Avizen Biopharma Private Limited reported revenue of ₹20.61 Cr (up 272% YoY) for FY 2025.

Revenue · FY 2025
₹20.61 Cr ▲ 272%
Net profit · FY 2025
₹32.92 Lakh margin 1.6%
EBITDA · FY 2025
₹1.1 Cr margin 5.3%

Compounded Annual Growth Rate (CAGR) of Avizen Biopharma Private Limited

Revenue CAGR growth
1 year
▲ 272%
3 years · compounded
▲ 65%
5 years · compounded
▲ 68%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 98%
5 years · compounded
▲ 36%

Revenue has grown at a compounded annual rate (CAGR) of 68% over five years, including 272% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Avizen Biopharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.1 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹32.92 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Avizen Biopharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.3%••••••••••••••••
Net Profit Margin1.6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Avizen Biopharma are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Auditor Details of Avizen Biopharma Private Limited

Avizen Biopharma Private Limited is audited by Hari Singh & Associates for the financial year 2024.

NameStatusAppointment DateCessation Date
Hari Singh & AssociatesLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Avizen Biopharma Private Limited

Avizen Biopharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajendra Kumar VermaDirector09 Aug 201610 Years 1 MonthsCurrent
Mahendra Kumar VermaDirector09 Aug 201610 Years 1 MonthsCurrent
Sunil Kumar KhemaniDirector25 Feb 20179 Years 7 MonthsCurrent
Alka VermaDirector17 Jul 20251 Years 2 MonthsCurrent

Ownership and Shareholding of Avizen Biopharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Avizen Biopharma Private Limited

Open charges
₹6.1 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹6.10 Cr
Latest charge details
DateLenderAmountStatus
04 Dec 2021Others₹18.5 LakhOpen
29 Sep 2020Others₹36.8 LakhOpen
30 Mar 2017Others₹5.55 CrOpen

Total charge records: 3 View all charges

Employees and EPFO Compliance at Avizen Biopharma Private Limited

Avizen Biopharma Private Limited has a workforce of 13 employees as of Feb 17, 2025.

Employee count
13
Active EPFO establishments
1
Employee growth
18.18%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Avizen Biopharma Private Limited

Charges
14 Aug 2025
A charge with Others of Rs. 5.55 Cr registered on 30 Mar 2017 with Charge ID 100094089 was modified on 14 Aug 2025.
Directors
17 Jul 2025
Alka Verma was appointed as a Director on 17 Jul 2025 & has been associated with this company since 1 year 2 months.
Activity
30 Sep 2024
Avizen Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Avizen Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati.
Charges
04 Dec 2021
A charge with Others amounted to Rs. 0.19 Cr with Charge ID 100516420 was registered on 04 Dec 2021.
Charges
29 Sep 2020
A charge with Others amounted to Rs. 0.37 Cr with Charge ID 100397271 was registered on 29 Sep 2020.

Credit Ratings, Litigation & Regulatory Alerts for Avizen Biopharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Avizen Biopharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Avizen Biopharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Avizen Biopharma Private Limited

Avizen Biopharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
18AAOCA6748E1ZCAssamActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Avizen Biopharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avizen Biopharma Private Limited

Avizen Biopharma is an active private limited company based in Guwahati, Assam, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 August 2016 (10+ years old) and is registered under CIN U24304AS2016PTC017532.

Avizen Biopharma reported revenue of ₹20.61 Cr for FY 2025 (up 272% YoY).

Avizen Biopharma has 4 current directors:

Avizen Biopharma reported a net profit of ₹32.92 Lakh (net margin 1.6%) and EBITDA of ₹1.1 Cr (EBITDA margin 5.3%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Avizen Biopharma is 65% over three years and 68% over five years. In the latest year (FY 2025) revenue rose 272%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Avizen Biopharma is 18AAOCA6748E1ZC, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Avizen Biopharma is U24304AS2016PTC017532. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Avizen Biopharma has 5 court cases on record: 2 filed by the company and 3 filed against it. 3 are pending. Most are in the district courts.

Avizen Biopharma was incorporated on 09 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Guwahati.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available